What is he best known for?
The fields of study he is best known for:
- Cancer
- Gene
- Internal medicine
His scientific interests lie mostly in Pathology, Immunology, Mycosis fungoides, Lymphoma and Antigen.
Gary S. Wood has researched Pathology in several fields, including Peripheral T-cell lymphoma and Immunophenotyping.
Many of his research projects under Immunology are closely connected to Primary cutaneous marginal zone lymphoma with Primary cutaneous marginal zone lymphoma, tying the diverse disciplines of science together.
His Mycosis fungoides research integrates issues from Stage, Gene rearrangement, Oncology and Survival rate.
In general Lymphoma study, his work on Lymphoproliferative disorders often relates to the realm of Large cell, thereby connecting several areas of interest.
His Antigen study integrates concerns from other disciplines, such as Molecular biology, Antibody, Macrophage and Monocyte.
His most cited work include:
- Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). (945 citations)
- Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma (526 citations)
- Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. (491 citations)
What are the main themes of his work throughout his whole career to date?
His primary scientific interests are in Pathology, Immunology, Mycosis fungoides, Lymphoma and Cutaneous T-cell lymphoma.
His Pathology research integrates issues from T lymphocyte, Immunophenotyping and Antigen.
He works mostly in the field of Immunology, limiting it down to concerns involving Cytotoxic T cell and, occasionally, CD8.
He works mostly in the field of Mycosis fungoides, limiting it down to topics relating to Gene rearrangement and, in certain cases, Southern blot.
His Lymphoma research includes elements of T cell, Cancer, Disease and Virus.
His Cutaneous T-cell lymphoma study combines topics in areas such as Apoptosis and Cancer research.
He most often published in these fields:
- Pathology (46.43%)
- Immunology (35.32%)
- Mycosis fungoides (31.35%)
What were the highlights of his more recent work (between 2011-2020)?
- Cancer research (20.63%)
- Cutaneous T-cell lymphoma (24.60%)
- Mycosis fungoides (31.35%)
In recent papers he was focusing on the following fields of study:
Gary S. Wood spends much of his time researching Cancer research, Cutaneous T-cell lymphoma, Mycosis fungoides, Apoptosis and Immunology.
Gary S. Wood has researched Cutaneous T-cell lymphoma in several fields, including T cell, Interleukin 12, Epigenetic therapy and Polo-like kinase.
He is researching Mycosis fungoides as part of the investigation of Lymphoma, Internal medicine and Pathology.
His study in Pathology is interdisciplinary in nature, drawing from both Cancer and Transplantation.
Gary S. Wood combines subjects such as Molecular biology and Epidermis with his study of Apoptosis.
His research investigates the connection with Immunology and areas like Disease which intersect with concerns in Etiology, Angiosarcoma and Dermatofibrosarcoma protuberans.
Between 2011 and 2020, his most popular works were:
- Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model (178 citations)
- Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project (162 citations)
- Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas. (96 citations)
In his most recent research, the most cited papers focused on:
- Cancer
- Gene
- Internal medicine
Gary S. Wood mainly focuses on Mycosis fungoides, Immunology, Internal medicine, Psoriasis and Cancer research.
Lymphoma and Pathology are all intrinsically tied to his study in Mycosis fungoides.
His research on Pathology frequently links to adjacent areas such as Transplantation.
His biological study spans a wide range of topics, including Pachyonychia congenita, Epidermolysis bullosa simplex, Genetic enhancement and Drug discovery.
His Internal medicine research is multidisciplinary, incorporating perspectives in Surgery and Oncology.
His studies deal with areas such as Lymphoproliferative disorders, Cutaneous T-cell lymphoma, Apoptosis, Cell cycle and Combination therapy as well as Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
